Dingdang Health Technology Group Ltd. (HK:9886)
:9886
Want to see HK:9886 full AI Analyst Report?
9886 Stock Chart & Stats
HK$1.08
-HK$0.02(-3.23%)
At close: 4:00 PM EST
HK$1.08
-HK$0.02(-3.23%)
Day’s Range― - ―
52-Week RangeHK$0.46 - HK$1.37
Previous CloseN/A
Volume431.00K
Average Volume (3M)4.91M
Market Cap
HK$1.02B
Enterprise ValueHK$721.01M
Total Cash (Recent Filing)HK$1.36B
Total Debt (Recent Filing)HK$263.13M
Price to Earnings (P/E)―
Beta1.79
Next Earnings
Aug 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding1,254,649,400
10 Day Avg. Volume8,114,443
30 Day Avg. Volume4,906,414
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)0.75
Price to Sales (P/S)0.26
P/FCF Ratio10.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.07
Revenue Forecast (FY)HK$6.85B
Bulls Say, Bears Say
Bulls Say
Revenue RecoveryA 70% top-line rebound in 2025 indicates a durable demand recovery for the company's O2O pharmacy model. Strong revenue growth restores scale economics, helps absorb fixed costs, and creates capacity to reinvest in delivery and digital capabilities if the trend persists.
Margin ImprovementExpansion of gross margin to ~35.3% points to better pricing, product mix, or cost control, improving the ability to convert sales into operating profits. Higher gross margins enhance operating leverage and increase the likelihood that incremental revenue will flow through to sustainable earnings.
Improved Cash GenerationThe swing to positive operating (~155M) and free cash flow (~123M) materially improves liquidity and financial flexibility. Consistent cash generation supports capex, working capital, and deleveraging, strengthening the firm's ability to fund growth without immediate external financing.
Bears Say
Residual UnprofitabilityAlthough losses narrowed, the company remains slightly unprofitable (~-1.0%) and has a history of sizable multi-year losses. Persistent negative net income limits retained-earnings accumulation, weakens returns on equity, and increases reliance on external capital to sustain strategic investments.
Historical Balance-Sheet StressPrior episodes of negative equity and elevated debt (2020–2021) reflect execution and capital-structure weakness. Even with current manageable leverage, this history can constrain credit access, raise borrowing costs, and leave residual covenant or refinancing risks during adverse cycles.
Cash-Flow VolatilityCash flow generation has been volatile, with negative operating/free cash flow from 2020–2024 and a one-year turnaround in 2025. This raises concerns that 2025's improvement could be driven by working-capital timing or non-recurring items, reducing predictability of internal funding for growth.
Dingdang Health Technology Group Ltd. News
9886 FAQ
What was Dingdang Health Technology Group Ltd.’s price range in the past 12 months?
Dingdang Health Technology Group Ltd. lowest stock price was HK$0.46 and its highest was HK$1.37 in the past 12 months.
What is Dingdang Health Technology Group Ltd.’s market cap?
Dingdang Health Technology Group Ltd.’s market cap is HK$1.02B.
When is Dingdang Health Technology Group Ltd.’s upcoming earnings report date?
Dingdang Health Technology Group Ltd.’s upcoming earnings report date is Aug 21, 2026 which is in 76 days.
How were Dingdang Health Technology Group Ltd.’s earnings last quarter?
Dingdang Health Technology Group Ltd. released its earnings results on Mar 20, 2026. The company reported HK$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.002.
Is Dingdang Health Technology Group Ltd. overvalued?
According to Wall Street analysts Dingdang Health Technology Group Ltd.’s price is currently Overvalued.
Does Dingdang Health Technology Group Ltd. pay dividends?
Dingdang Health Technology Group Ltd. does not currently pay dividends.
What is Dingdang Health Technology Group Ltd.’s EPS estimate?
Dingdang Health Technology Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dingdang Health Technology Group Ltd. have?
Dingdang Health Technology Group Ltd. has 1,254,649,400 shares outstanding.
What happened to Dingdang Health Technology Group Ltd.’s price movement after its last earnings report?
Dingdang Health Technology Group Ltd. reported an EPS of HK$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.205%.
Which hedge fund is a major shareholder of Dingdang Health Technology Group Ltd.?
Currently, no hedge funds are holding shares in HK:9886
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dingdang Health Technology Group Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
80.00%
12-Months-Change
Fundamentals
Return on Equity
-2.95%
Trailing 12-Months
Asset Growth
12.67%
Trailing 12-Months
Company Description
Dingdang Health Technology Group Ltd.
Dingdang Health Technology Group Ltd. operates as a service provider in the digital retail pharmacy industry in the People's Republic of China. The company offers pharmaceutical retail and medical consultation services. Dingdang Health Technology Group Ltd. was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.
Technical Analysis
Innovative Pharmaceutical Biotech
―
Natural Beauty Bio-Technology
―
Cheerwin Group Limited
―
EC Healthcare
―
Giant Biogene Holding Co. Ltd.
―
Options Prices
Currently, No data available
---